HROW
Harrow Health, Inc.NASDAQHealthcare$35.31-0.34%ClosedMarket Cap: $1.31B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
24.75
P/S
4.83
EV/EBITDA
39.22
DCF Value
$-566.60
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.1%
Operating Margin
11.2%
Net Margin
-1.9%
ROE
-10.0%
ROA
-2.3%
ROIC
5.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $89.1M | 79.3% | $15.6M | $6.6M | $0.18 | — |
| FY 2025 | $272.3M | 75.1% | $36.4M | $-5.1M | $-0.14 | — |
| Q3 2025 | $71.6M | 75.3% | $14.7M | $1.0M | $0.03 | — |
| Q2 2025 | $63.7M | 74.5% | $11.4M | $5.0M | $0.13 | — |
| Q1 2025 | $47.8M | 67.5% | $-11.2M | $-17.8M | $-0.50 | — |
| Q4 2024 | $66.8M | 78.8% | $12.9M | $6.8M | $0.19 | — |
| FY 2024 | $199.6M | 75.3% | $8.8M | $-17.5M | $-0.49 | — |
| Q3 2024 | $49.3M | 75.6% | $1.3M | $-4.2M | $-0.12 | — |
| Q2 2024 | $48.9M | 74.4% | $1.5M | $-6.5M | $-0.18 | — |
| Q1 2024 | $34.6M | 69.5% | $-6.9M | $-13.6M | $-0.38 | — |
| Q4 2023 | $36.4M | 68.9% | $-4.9M | $-9.1M | $-0.26 | — |
| FY 2023 | $130.2M | 69.6% | $431.0K | $-24.4M | $-0.75 | — |